Back to Agenda
Risk-Based Monitoring: Convergence of Technology, Processes, and People
Session Chair(s)
Mary Arnould, BSN, MSN
Director, Clinical Science Operations, Astellas, United States
Real-life challenges and lessons learned. Impact on traditional roles, new opportunities, cross-functional collaboration, identifying data trends and issues.
Learning Objective : Define key challenges in RBM implementation; Describe how processes and roles need to change in the organization to support the RBM; Demonstrate how results from analytics can be turned into actionable items to mitigate risks.
Speaker(s)
Mary Arnould, BSN, MSN
Director, Clinical Science Operations, Astellas, United States
Five Years of Global Risk-Based Monitoring Implementation: Where We’ve Been and Where We’re Going - Best Practices and Lessons Learned
Steve Young, MSC
Chief Scientific Officer, CluePoints, United States
Risk-Based Monitoring Centralized Monitoring: What's Needed to be Effective?
Keith Dorricott
MCC Ambassador; Director, Dorricott Metrics and Process Improvement Ltd., United Kingdom
The Evolving Area of Central Monitoring: What is it? What Data is Being Reviewed? Who is Responsible?
Have an account?
